SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors aggressively position ahead of its earnings report, with community sentiment split between high expectations for a major hyperscaler contract and fears of a sell-off if the news fails to materialize. Traders are closely monitoring heavy options activity and sector-wide momentum in AI infrastructure, with many debating whether to hold through potential volatility or lock in profits from the stock's recent gains.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is experiencing intense volatility as investors speculate on a potential short squeeze and a rumored partnership with OpenAI ahead of earnings. Community sentiment remains deeply polarized, with many traders frustrated by consistent intraday sell-offs while others aggressively defend their positions based on the CEO's recent large-scale share purchases.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense community speculation as investors position themselves ahead of upcoming earnings, with many anticipating that a shift toward improved unit economics and strategic acquisitions will trigger a significant breakout. Discussion is dominated by bullish sentiment regarding the company's long-term path to profitability and potential for a short squeeze, while traders weigh the impact of shifting mortgage dynamics and recent operational updates.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing intense community focus ahead of its quarterly earnings release, with investors closely watching for updates on its Neutron rocket program, defense contract conversions, and revenue growth. Sentiment remains bullish, as market participants look past recent volatility, citing the company's expanding backlog and position as a key strategic partner in the growing space defense and satellite infrastructure sectors.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing a significant surge in social media activity as investors position themselves ahead of the upcoming earnings release, debating whether the stock will trigger a major short squeeze given its high short interest and institutional accumulation. The community remains sharply divided, with bulls pointing to strong AI growth narratives and potential partnerships, while bears continue to raise concerns regarding the company's path to profitability and recent valuation run-up.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing extreme volatility as investors weigh massive revenue growth and hyperscaler tailwinds against concerns over heavy debt, rising capital expenditures, and significant insider selling ahead of the earnings report. The community remains sharply divided, with bulls betting on a breakout fueled by AI demand, while bears anticipate a post-earnings sell-off due to the company's historical volatility and high burn rate.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is facing extreme market volatility as investors weigh the significant risk of a negative regulatory outcome against the potential for an FDA approval catalyst. The community is heavily focused on the company's precarious cash position and the possibility of dilutive financing, with many debating whether the stock is a high-risk squeeze opportunity or headed for further downside.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is currently the focus of investor attention as it faces high-stakes earnings after a round of workforce reductions and ongoing debate surrounding the Clarity Act. Market participants are actively weighing concerns about the company's cost structure and competitive positioning against bullish sentiment regarding institutional adoption and its evolving role in financial infrastructure.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing extreme volatility and a sharp sell-off following quarterly earnings that investors are viewing as a 'sell the news' event despite reported growth. The community is actively debating whether the stock is a deep-value buying opportunity or if the current momentum suggests a continued slide, with many traders questioning why the market reaction has been so severe given the company's raised guidance.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors weigh potential impacts from the emerging prediction market sector and upcoming first-quarter earnings, leading to intense community debate over long-term growth prospects. Discussions are dominated by speculation on whether these new markets will cannibalize traditional sports betting revenue or serve as an additive growth driver for the platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UBS Group AG Raises Stock Position in Caris Life Sciences, Inc. $CAI

UBS Group AG lifted its stake in shares of Caris Life Sciences, Inc. (NASDAQ:CAI - Free Report) by 825.9% during the fourth quarter, according to the company in its most recent Form 13F filing with...

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant...

Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies

Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies Caris Life Sciences Receives MolDX Approval for Caris...

Caris Life Sciences (NASDAQ:CAI) Downgraded by Wall Street Zen to Hold

Wall Street Zen lowered Caris Life Sciences from a "buy" rating to a "hold" rating in a report on Saturday...

Caris Life Sciences (NASDAQ:CAI) Shares Gap Down - Here's What Happened

Caris Life Sciences (NASDAQ:CAI) Shares Gap Down - Time to Sell...

Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients

Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide...

Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Average Rating of "Hold" from Brokerages

Shares of Caris Life Sciences, Inc. (NASDAQ:CAI - Get Free Report) have received a consensus recommendation of "Hold" from the seven ratings firms that are currently covering the stock, MarketBeat...

Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference

Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference Caris Life Sciences to Present at the BofA Securities...

146,100 Shares in Caris Life Sciences, Inc. $CAI Bought by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale bought a new stake in Caris Life Sciences, Inc. (NASDAQ:CAI - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and...

TD Waterhouse Canada Inc. Makes New Investment in Caris Life Sciences, Inc. $CAI

TD Waterhouse Canada Inc. bought a new position in Caris Life Sciences, Inc. (NASDAQ:CAI - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm...

Caris Life Sciences Inc.

CAI  Earnings Call

Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.

CAI
Caris Life Sciences Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest CAI News

CAICaris Life Sciences Inc.